- ISIN
- US12482W1018
- CUSIP
- 12482W101
- Sector
- Healthcare
- IPO Date
- Apr 29, 2019
Highlights
- Market Cap
- $7.31M
- Enterprise Value
- -$1.82B
- EPS (TTM)
- -$102.92
- Total Revenue (TTM)
- $5.65B
- Gross Profit (TTM)
- $3.26B
- EBITDA (TTM)
- -$801.36M
- Year Range
- $0.47 - $2.56
- ROA (TTM)
- -7.17%
- ROE (TTM)
- -9.46%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
YCBD Performance Chart
cbdMD, Inc. (YCBD) is down 48.1% since the beginning of the year. At $1 per share, YCBD is trading 72.7% below its 52-week high of $3. Investors who bought $1,000 worth of YCBD shares 5 years ago would now be looking at an investment worth $1.
Loading charts...
Returns By Period
cbdMD, Inc. (YCBD) has returned -48.14% so far this year and -28.52% over the past 12 months.
cbdMD, Inc.
- 1D
- -6.65%
- 1M
- -18.20%
- YTD
- -48.14%
- 6M
- 18.14%
- 1Y
- -28.52%
- 3Y*
- -64.40%
- 5Y*
- -77.03%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.74%
- 1M
- 4.90%
- YTD
- 10.35%
- 6M
- 10.28%
- 1Y
- 26.52%
- 3Y*
- 20.83%
- 5Y*
- 12.30%
- 10Y*
- 13.66%
YCBD Monthly Returns History
Based on dividend-adjusted daily data since Apr 29, 2019, YCBD's average daily return is -0.17%, while the average monthly return is -4.62%.
Historically, 31% of months were positive and 69% were negative. The best month was Dec 2025 with a return of +118.5%, while the worst month was Apr 2023 at -62.6%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 11 months.
On a daily basis, YCBD closed higher 43% of trading days. The best single day was Sep 29, 2025 with a return of +121.2%, while the worst single day was May 1, 2023 at -40.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -22.96% | -11.85% | -19.07% | 17.09% | -8.84% | -11.60% | -48.14% | ||||||
| 2025 | 52.53% | -30.45% | -42.18% | -5.43% | -43.10% | -9.92% | 0.58% | -17.61% | 63.73% | -27.73% | -29.33% | 118.45% | -55.00% |
| 2024 | -24.44% | -14.61% | 38.60% | 18.28% | -39.64% | -11.14% | -1.71% | -6.19% | -13.60% | 8.51% | -3.33% | -23.94% | -63.94% |
| 2023 | 51.63% | -29.69% | -19.42% | -62.62% | -42.07% | -26.32% | 3.57% | -20.68% | -10.01% | -42.99% | 18.61% | 48.59% | -89.82% |
| 2022 | -3.70% | -17.31% | 20.93% | -38.46% | 7.83% | -36.21% | 9.06% | -16.87% | -43.60% | 46.60% | -18.18% | -15.93% | -78.98% |
| 2021 | 18.64% | 6.86% | 10.70% | -7.00% | -21.30% | -4.29% | -11.03% | -16.67% | -3.26% | -14.90% | -5.08% | -35.71% | -63.39% |
Benchmark Metrics
cbdMD, Inc. has an annualized alpha of -43.97%, beta of 1.02, and R2 of 0.03 versus S&P 500 Index. Calculated based on daily prices since April 30, 2019.
- This stock participated in 223.30% of S&P 500 Index downside but only -76.98% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.03 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -43.97%
- Beta
- 1.02
- R²
- 0.03
- Upside Capture
- -76.98%
- Downside Capture
- 223.30%
Return for Risk
Risk / Return Rank
YCBD ranks 43 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for cbdMD, Inc. (YCBD) and compare them to S&P 500 Index.
| YCBD | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.39 | ||
| Sortino ratioReturn per unit of downside risk | -1.69 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 1.41 | -0.26 |
| Calmar ratioReturn relative to maximum drawdown | -0.40 | 2.93 | -3.33 |
| Martin ratioReturn relative to average drawdown | -0.60 | 13.52 | -14.12 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the cbdMD, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the cbdMD, Inc. was 99.98%, occurring on Nov 21, 2025. The portfolio has not yet recovered.
The current cbdMD, Inc. drawdown is 99.97%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2025 bear market2025 | -99.98%Nov 2025 | 6y 6mo | — | 7y 24dMay 2019 - now |
2019 correction2019 | -19.61%May 2019 | 1d | 2d | 3dMay 2019 - May 2019 |
2019 pullback2019 | -3.29%May 2019 | 2d | 3d | 5dMay 2019 - May 2019 |
Drawdown Indicators
| YCBD | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.98% | -56.78% | -43.20% |
Max Drawdown (1Y)Largest decline over 1 year | -71.19% | -9.10% | -62.09% |
Max Drawdown (3Y)Largest decline over 3 years | -96.91% | -18.90% | -78.01% |
Max Drawdown (5Y)Largest decline over 5 years | -99.96% | -25.43% | -74.53% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -99.97% | -0.74% | -99.23% |
Average DrawdownAverage peak-to-trough decline | -82.45% | -10.72% | -71.73% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 47.52% | 1.97% | +45.55% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of cbdMD, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how cbdMD, Inc. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for YCBD relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, YCBD has a P/S ratio of 0.0. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for YCBD in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, YCBD has a P/B value of 0.0. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with YCBD
Add cbdMD, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with YCBD